Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Joseph J. Echevarria Elected To Pfizer’s Board Of Directors

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately. Mr. Echevarria also was appointed to the Audit, Regulatory and Compliance and Science and Technology Committees of Pfizer’s Board. Mr. Echevarria, 58, retired as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional […]

Read More »

Aquinox’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial

An experimental bladder pain syndrome/ interstitial cystitis drug being developed by immuno-oncology drugmaker Aquinox Pharmaceuticals, Inc. (AQXP) failed to meet its statistical endpoint during a mid-stage clinical trial, the company announced this morning. AQX-1125, Aquinox’s lead drug candidate, did not diminish pain in trial patients compared to those who took a placebo during a six […]

Read More »

PAREXEL International to Cut 850 Jobs As New Guidance, Pfizer Flow Force Restructuring

Boston, Mass.-based PAREXEL International (PRXL), a contract research organization (CRO), in conjunction with its earning guidance Tuesday, also indicated it would be laying off 850 people as part of restructuring. The restructuring process is company-wide with the goal of improving productivity and efficiency, simplifying the company’s organization and streamlining decision-making. As part of the job […]

Read More »

Study Shows Wearing Contact Lenses Increases Risk Of Drooping Upper Eyelids

NEW YORK, June 25, 2015 /PRNewswire-USNewswire/ — A recent study published in the Aesthetic Surgery Journal, the official publication of the American Society for Aesthetic Plastic Surgery (ASAPS), showed both hard and soft contact lenses contributed to the drooping of the upper eyelids, a medical condition referred to as ptosis. The severity of the drooping eyelids […]

Read More »

Bristol-Myers Squibb Expands R&D Presence Within Hubs of World Class Science and Innovation

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence and innovation with the opening of a new state-of-the-art research site in Cambridge, Mass. in addition to the ongoing expansion of the company’s R&D Discovery […]

Read More »

Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer

Immunovaccine and Incyte to Co-Fund Clinical Trial Combining DPX-Survivac and Epacadostat for Patients with Recurrent Disease HALIFAX, NOVA SCOTIA–(Marketwired – June 25, 2015) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it has entered into a non-exclusive clinical trial collaboration with Incyte Corporation (Nasdaq: […]

Read More »

Eli Lilly wins UK Alimta drug patent case on appeal

Eli Lilly has won a patent case in the Court of Appeal in London over its blockbuster Alimta lung cancer drug, boosting prospects for future sales and dealing a blow to generic challenger Actavis. Alimta generated worldwide sales of $2.79 billion for Lilly last year, making the medicine its biggest-selling product. The verdict, which reverses […]

Read More »

Cynapsus Therapeutics’ APL-130277 Improved Parkinson’s Symptoms and Rapidly Turned Patients from OFF to ON

Data Presented at the International Congress of Parkinson’s Disease and Movement Disorders APL-130277, Sublingual Apomorphine, for On-Demand Treatment of OFF Episodes Associated with Parkinson’s Disease TORONTO, ONTARIO–(Marketwired – June 25, 2015) – Cynapsus Therapeutics Inc. (NASDAQ:CYNA)(TSX:CTH) (the “Company”) today announced that it presented data from clinical trials of APL-130277, a sublingual apomorphine thin film under […]

Read More »

Orexo’s “Out the Monster” campaign wins a Gold Lions Health Award at the Cannes Lions Festival

MORRISTOWN, N.J.–(BUSINESS WIRE)–Regulatory News: Orexo: (STO:ORX) Orexo’s “Out the Monster” campaign came out on top with a Gold Lions Health Award at the Cannes Lions Festival in France on June 19th. The Lions Health Awards recognize the most creative ideas in the healthcare and pharmaceutical communications industry. “Out the Monster” is a disease awareness campaign featuring […]

Read More »

Cancer Vaccines Market Growing at 27% CAGR to 2019

DALLAS, June 25, 2015 /PRNewswire/ — The Global Cancer Vaccines Market 2015-2019 report says use of vaccines in combination with other therapies is propelling the growth of cancer vaccines market across the world in addition to frequent occurrence of different types of cancer and the introduction of various cancer vaccines. Complete report on cancer vaccines […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom